Email: info@grantinc.com

Phone (201) 791-8700

Fax. (201) 791-0038




We're known for our award-winning products and cutting-edge research. Discover why quality and innovation go hand-in-hand with being a family-owned business. [More]

Granactive AR-1423

Anti-Redness Peptide Matrix

Soothing Vibrant Skin Toning Effects



Features and Benefits:
  • Proven Redness Reduction
  • Improved Skin Health
  • Superior Skin Soother
  • Enhances Skin’s Appearance
  • Anti-Inflammatory Effects
  • Reduces Likelihood of Post Inflammatory Pigmentation


INCI Name:
Water (and) Butylene Glycol (and) Camellia Sinensis (Tea) Extract (and) Aspalathus Linearis (Rooibos) Extract (and) Boswellia Serrata Extract (and) Honey Extract (and) Tetrapeptide-14 (and) Phenoxyethanol (and) Sodium Benzoate

Recommended Use Levels:
5%

Safety:
Non-irritating, Non-sensitizing

Availability:
Globally

Applications:
  • Daily Wear
  • Moisturizers
  • Skin Toners
  • Night Moisturizers


   
Tetrapeptide-14 Delivery Matrix
Granactive AR-1423 is a unique delivery matrix which combines a redness diminishing peptide with the anti-oxidant properties of tea, the calming properties of boswellia serrata and the soothing quality of honey. Granactive AR-1423 contains Tetrapeptide-14, a specific peptide sequence that can be used in cosmetic treatments to alleviate the redness associated with rosacea or mild sun exposure. It acts by down regulating interleukin-6 (IL-6) to prevent inflammation, which in turn reduces MMP-1 damage with the net effect of a bright and even skin appearance.

Granactive AR-1423 Full Face Redness Study
Granactive AR-1423 was evaluated in a leave-on cosmetic treatment at a 5% level on several subjects having redness associated with rosacea. This cosmetic treatment was effective at diminishing the redness by 50% over the course of the 4 week study.



Inflammation Due to UV-B Exposure
UVB causes inflammation by increasing interleukin-6 in keratinocytes. The IL-6 then induces fibroblasts to produce MMP-1 (matrix metalloproteinase-1), an enzyme that breaks-down the extra-cellular matrix leading to photoaging. The following dataset demonstrates the superior ability of tetrapeptide-14 to reduce IL-6 in keratinocytes and rapid reduce MMP-1 in fibroblasts to simultaneously alleviate inflammation and photoaging.


Puffy Eye Study
A 6 week, 4 subjects study demonstrates tetrapeptide-14 dramatic reduction of puffiness under the eye. The photo on the left displays tetrapeptide-14 ability to noticeably reduce puffiness in 2 weeks. A mean value of 42.86% puffiness reduction was observed during the 6 week study.